Efficacy and Cost Analysis for Acitretin for Basal and Squamous Cell Carcinoma Prophylaxis in Renal Transplant Recipients

Dermatol Surg. 2021 Jan 1;47(1):125-126. doi: 10.1097/DSS.0000000000002423.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Review

MeSH terms

  • Acitretin / economics*
  • Acitretin / therapeutic use
  • Carcinoma, Basal Cell / drug therapy*
  • Carcinoma, Squamous Cell / drug therapy*
  • Costs and Cost Analysis
  • Humans
  • Keratolytic Agents / economics*
  • Keratolytic Agents / therapeutic use
  • Kidney Transplantation*
  • Skin Neoplasms / drug therapy*
  • Transplant Recipients

Substances

  • Keratolytic Agents
  • Acitretin